HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Drug Pipeline
Sys. Review
Narrative review of phytochemicals in zebrafish models for metabolic dysfunction-associated steatotic liver disease and related conditions
Tiny fish help find new safe liver disease drugs
This narrative review examines preclinical data on phytochemicals using zebrafish models for metabolic dysfunction-associated steatotic live…
Tiny zebrafish are helping scientists test plant-based medicines for liver disease faster than ever before while checking safety and toxicit…
Frontiers
Apr 28, 2026
Rheumatology
Cohort
High aMAP Risk Scores Associated With Increased Mortality in Metabolic and Alcohol-Related Liver Disease
New Score Predicts Liver Disease Death Risk Across All Types
This cohort study analyzed 32,654 NHANES participants and 642 from a Southern Chinese cohort to evaluate the aMAP risk score.
A new blood test score helps doctors spot patients with fatty liver disease who face a higher risk of dying soon.
Frontiers
Apr 25, 2026
Gastroenterology
Sys. Review
Literature review synthesizes Schisandra chinensis effects on gut microbiota and metabolic pathways across multiple conditions
This Ancient Berry May Quiet Inflammation From Your Gut to Your Brain
This literature review examines the potential of Schisandra chinensis regarding gut health and metabolic regulation.
An ancient berry used for centuries may rebalance gut bacteria to calm inflammation linked to digestive issues, liver disease, diabetes, and…
Frontiers
Apr 19, 2026
Diabetes & Endocrinology
Observational study links semaglutide dose and weight loss to lower liver disease risk
Study links semaglutide use to lower risk of several liver conditions in patients with liver disease
This observational study from a real-world federated EHR network analyzed 6,734 patients with liver disease.
Higher semaglutide doses and greater weight loss were linked to lower risks of steatohepatitis, alcoholic liver disease, and death in patien…
medRxiv
Apr 19, 2026
Gastroenterology
Sys. Review
Systematic review finds inconsistent microbiome findings in alcohol-associated liver disease
Can fixing your gut help heal a liver damaged by alcohol?
A systematic review examined gut microbiome interactions and therapeutic strategies in patients with alcohol-associated liver disease.
Fixing gut bacteria with probiotics or transplants might help heal alcohol-damaged livers, but inconsistent study results make it hard to kn…
Frontiers
Apr 2, 2026
Gastroenterology
Meta-analysis
Oyster-derived bioactives show hepatoprotective effects in animal models of alcoholic liver disease
Could oyster compounds help protect the liver from alcohol damage?
A systematic review and meta-analysis of 11 studies (10 animal, 1 human trial) found oyster-derived compounds reduced liver enzymes by 34-56…
Oyster compounds may protect the liver from alcohol damage in animals by lowering injury markers and boosting antioxidant defenses, though h…
Frontiers
Apr 2, 2026